Notícias Apogee Therapeutics Inc - APGE | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Apogee Therapeutics Inc (APGE)
Apogee Therapeutics Inc (APGE) Notícias

Apogee Therapeutics Inc (APGE)

40,32

0,19

(0,47%)

Fechado 29 Janeiro 6:00PM

Atrasado por 15 minutos

40,42

0,10

( 0,25% )

Pré-mercado: 11:27AM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Apogee Therapeutics to Participate at the Guggenheim SMID Cap Biotech Conference

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Apogee Therapeutics Highlights Progress and Best-in-Class Potential of Novel Biologic Programs for I&I Diseases at 2024 Inaugural R&D Day

Apogee Therapeutics Announces Agenda for Virtual R&D Day

Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Apogee Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições